1213 Tumor-ECM targeted IL-12: improved safety and efficacy in clinically relevant settings

1213 Tumor-ECM targeted IL-12: improved safety and efficacy in clinically relevant settings

Bibliographic Details
Main Author:	Jun Ishihara
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Trichodermin (4β-acetoxy-12,13-epoxytrichothec-9-ene)
by: Fu-Cheng Lin, et al.
Published: (2008-04-01)

Brown adipose tissue and the take (12,13-di)HOME message to the heart
by: Badi, I, et al.
Published: (2021)

Trichodermol (4&#945;-hydroxy-12,13-epoxytrichothec-9-ene)
by: Jing-Li Cheng, et al.
Published: (2009-11-01)

James I of Aragon (1213–1276)
by: Marta Serrano-Coll
Published: (2021-11-01)

Deciphering the Relevance of Bone ECM Signaling
by: Natividad Alcorta-Sevillano, et al.
Published: (2020-12-01)

Site-Selective Modification of a Porpholactone—Selective Synthesis of 12,13- and 17,18-Dihydroporpholactones
by: Ana F. R. Cerqueira, et al.
Published: (2020-06-01)

Dihalogenated trichodermin (4&#946;-acetoxy-9,10-dibromo-12,13-epoxytrichothec)
by: Jin-Hao Zhao, et al.
Published: (2010-01-01)

Sorafenib Induced Complete Cytogenetic and Molecular Response in a Chronic Eosinophilic Leukemia Case with t(12;13) Translocation
by: Federica Ricci, et al.
Published: (2020-07-01)

Como interpretar "ἐν ἑνὶ πνεύματι" e "εἰς ἓν σῶμα" em 1Coríntios 12,13
by: Clovis Torquato Junior, et al.
Published: (2019-08-01)

Fourier-Transform VUV Spectroscopy of <sup>14,15</sup>N and <sup>12,13</sup>C
by: Kin-Fung Lai, et al.
Published: (2020-09-01)

Metabolomics reveals increased isoleukotoxin diol (12,13-DHOME) in human plasma after acute Intralipid infusion
by: Lindsay M. Edwards, et al.
Published: (2012-09-01)

Preparative isolation and puriï¬cation of 12,13-dihydroxyeuparin from Radix Eupatorii Chinensis by high-speed counter-current chromatography
by: Mei Yang, et al.
Published: (2012-08-01)

Characterization of Extracellular Chitinase from Bacillus cereus SAHA 12.13 and Its Potency as a Biocontrol of Curvularia affinis
by: Muhammad Asril, et al.
Published: (2024-01-01)

12,13-diHOME and noradrenaline are associated with the occurrence of acute myocardial infarction in patients with type 2 diabetes mellitus
by: Ning Cao, et al.
Published: (2023-06-01)

rac-11-Selena-12,13-diazabicyclo[10.3.0]pentadeca-10a(13a),12-dien-1-ol
by: Heiner Detert, et al.
Published: (2021-01-01)

Clinical characteristics and diagnoses of 1213 children referred to a first seizure clinic
by: Geertruida Slinger, et al.
Published: (2024-04-01)

Modelling and Assessment of a New Triple-Frequency IF1213 PPP with BDS/GPS
by: Zhongyuan Wang, et al.
Published: (2022-09-01)

NHS-IL12, a Tumor-Targeting Immunocytokine
by: Greiner JW, et al.
Published: (2021-05-01)

8-{[(E)-3-(2-Chlorophenyl)acryloyloxy]imino}-12,13-epoxytrichethec-9-en-4-yl (E)-3-(2-chlorophenyl)acrylate
by: Xiao-Jun Xu, et al.
Published: (2011-11-01)

Remodeling the ECM: Implications for Metastasis and Tumor Dormancy
by: Julie S. Di Martino, et al.
Published: (2021-09-01)

SON-1210 - a novel bifunctional IL-12 / IL-15 fusion protein that improves cytokine half-life, targets tumors, and enhances therapeutic efficacy
by: John K. Cini, et al.
Published: (2023-12-01)

Relevance of Cell-ECM Interactions: From a Biological Perspective to the Mathematical Modeling
by: Preziosi Luigi, et al.
Published: (2015-01-01)

Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors
by: Qing Yang, et al.
Published: (2022-01-01)

Safety and efficacy of Tet-regulated IL-12 expression in cancer-specific T cells
by: Ahdab Alsaieedi, et al.
Published: (2019-03-01)

Correction: Zhu et al. Gait Analysis with Wearables Is a Potential Progression Marker in Parkinson’s Disease. <i>Brain Sci.</i> 2022, <i>12</i>, 1213
by: Sha Zhu, et al.
Published: (2023-10-01)

Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine
by: Christine M. Minnar, et al.
Published: (2024-01-01)

Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile
by: Qingnan Zhao, et al.
Published: (2019-06-01)

Localization of VEGF to Vascular ECM Is an Important Aspect of Tumor Angiogenesis
by: Weon-Kyoo You, et al.
Published: (2017-07-01)

Interview with the ECM Award winner 2022 and introducing the new ECM members
by: Kiho Son, et al.
Published: (2023-03-01)

Targeted Drug Delivery via the Use of ECM-Mimetic Materials
by: Jeongmin Hwang, et al.
Published: (2020-02-01)

Improved intratumoral penetration of IL12 immunocytokine enhances the antitumor efficacy
by: Keunok Jung, et al.
Published: (2022-10-01)

Improvement of the Electronic—Neuronal Interface by Natural Deposition of ECM
by: Tobias Weigel, et al.
Published: (2021-03-01)

Targeting Oncogenic Wnt/β-Catenin Signaling in Adrenocortical Carcinoma Disrupts ECM Expression and Impairs Tumor Growth
by: Morgan K. Penny, et al.
Published: (2023-07-01)

Larynx proteomics after jellyfish collagen IL: Increased ECM/collagen and suppressed inflammation
by: Andrew J. Bowen, et al.
Published: (2022-10-01)

Optimization Of Polyhydroxyalkanoate (PHA) Production By Burkholderia Cepacia BPT1213 Using Waste Glycerol As The Sole Carbon Source
by: Mohd Zain, Nor Fauziah
Published: (2017)

Lactiplantibacillus plantarum L47 and inulin alleviate enterotoxigenic Escherichia coli induced ileal inflammation in piglets by upregulating the levels of α-linolenic acid and 12,13-epoxyoctadecenoic acid
by: Leihong Cui, et al.
Published: (2023-09-01)

Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer
by: Sikes Robert A, et al.
Published: (2004-01-01)

New insights into fibrosis from the ECM degradation perspective: the macrophage-MMP-ECM interaction
by: Xiangyu Zhao, et al.
Published: (2022-07-01)

The ECM Moves during Primitive Streak Formation—Computation of ECM Versus Cellular Motion.
by: Evan A Zamir, et al.
Published: (2008-10-01)

Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy
by: Vipul Bhatia, et al.
Published: (2023-04-01)